Profiles

Keywords
Last Name
Institution

Nancy Reau

Concepts (232)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hepatitis C, Chronic
29
2021
84
10.210
Why?
Antiviral Agents
32
2021
139
8.790
Why?
Hepatitis C
19
2021
68
6.900
Why?
Hepacivirus
22
2021
74
5.020
Why?
Liver Transplantation
8
2021
114
3.460
Why?
Liver Diseases
9
2021
40
3.210
Why?
Pregnancy Complications, Infectious
3
2020
34
2.180
Why?
Ribavirin
9
2016
32
1.930
Why?
Pregnancy Complications
5
2019
57
1.850
Why?
Infectious Disease Transmission, Vertical
3
2020
20
1.770
Why?
Liver Cirrhosis
10
2019
60
1.590
Why?
Sulfonamides
7
2020
64
1.410
Why?
Hepatitis B
5
2019
19
1.400
Why?
Interferon-alpha
5
2012
71
1.360
Why?
Polyethylene Glycols
5
2012
56
1.350
Why?
Pregnancy
10
2021
457
1.320
Why?
Humans
57
2021
31481
1.230
Why?
HIV Infections
4
2021
951
1.140
Why?
Carbamates
9
2020
12
1.120
Why?
Quinoxalines
5
2020
11
1.050
Why?
Drug Therapy, Combination
13
2021
265
1.020
Why?
United States
17
2021
2539
0.980
Why?
Treatment Outcome
20
2021
3910
0.920
Why?
Gastroenterology
3
2017
16
0.920
Why?
Liver Diseases, Alcoholic
2
2021
45
0.890
Why?
Living Donors
1
2021
16
0.880
Why?
Prejudice
1
2021
43
0.860
Why?
Female
33
2021
18253
0.860
Why?
Thrombocytopenia
1
2020
32
0.810
Why?
Postoperative Hemorrhage
1
2020
31
0.800
Why?
Elective Surgical Procedures
1
2020
55
0.800
Why?
Benzimidazoles
3
2019
15
0.790
Why?
Kidney Transplantation
2
2018
141
0.770
Why?
Patient Selection
1
2021
264
0.770
Why?
Genotype
10
2017
423
0.750
Why?
Hypertension, Pregnancy-Induced
1
2019
2
0.750
Why?
Viral Load
5
2016
213
0.710
Why?
Algorithms
2
2020
412
0.710
Why?
Fear
1
2018
51
0.690
Why?
Cholestasis, Intrahepatic
3
2019
6
0.690
Why?
Obesity
1
2021
338
0.680
Why?
Adult
21
2021
9779
0.660
Why?
Drugs, Generic
1
2016
4
0.620
Why?
Cyclopropanes
5
2020
27
0.620
Why?
Antacids
1
2016
1
0.620
Why?
Proton Pump Inhibitors
1
2016
15
0.610
Why?
Pregnancy Complications, Neoplastic
1
2016
4
0.610
Why?
Virology
1
2015
15
0.590
Why?
Middle Aged
21
2021
11209
0.570
Why?
Patient Readmission
1
2016
129
0.530
Why?
Length of Stay
2
2016
377
0.530
Why?
Coinfection
3
2019
33
0.520
Why?
Young Adult
9
2021
2277
0.500
Why?
Preventive Health Services
1
2013
16
0.500
Why?
Mass Screening
5
2021
199
0.490
Why?
Advisory Committees
1
2013
48
0.490
Why?
Health Policy
1
2013
52
0.480
Why?
Heart Failure
1
2016
232
0.470
Why?
Male
23
2021
17583
0.460
Why?
Disease Management
2
2016
147
0.450
Why?
Liver
2
2018
214
0.440
Why?
Lactams, Macrocyclic
4
2019
10
0.420
Why?
Proline
4
2019
22
0.420
Why?
Imidazoles
4
2020
74
0.410
Why?
Macrocyclic Compounds
4
2019
5
0.400
Why?
Recombinant Proteins
5
2012
295
0.400
Why?
Pregnancy Outcome
2
2021
20
0.400
Why?
Drug Resistance, Viral
4
2017
43
0.390
Why?
Bile Ducts, Intrahepatic
1
2008
7
0.350
Why?
Drug Administration Schedule
3
2018
257
0.350
Why?
Aged
14
2020
10295
0.340
Why?
Fatty Liver
2
2019
40
0.330
Why?
Anemia
1
2008
94
0.320
Why?
Retrospective Studies
8
2020
3591
0.320
Why?
Cohort Studies
6
2021
2014
0.320
Why?
Medication Adherence
2
2019
93
0.310
Why?
Liver Neoplasms
2
2019
117
0.310
Why?
Liver Function Tests
2
2019
33
0.300
Why?
Benzofurans
3
2020
8
0.290
Why?
Risk Factors
4
2020
2664
0.290
Why?
Graft Rejection
2
2018
84
0.280
Why?
Valine
4
2019
13
0.280
Why?
Prevalence
2
2020
544
0.280
Why?
Adolescent
4
2020
2667
0.270
Why?
Societies, Medical
2
2017
209
0.270
Why?
Drug Interactions
2
2015
70
0.270
Why?
Cost-Benefit Analysis
4
2021
153
0.260
Why?
Pyrrolidines
3
2018
21
0.260
Why?
Incidence
2
2020
829
0.250
Why?
Amides
2
2020
21
0.250
Why?
Prospective Studies
4
2019
1934
0.250
Why?
Risk Assessment
3
2018
806
0.250
Why?
Uracil
3
2019
5
0.240
Why?
Ritonavir
3
2019
18
0.240
Why?
Prognosis
3
2018
1028
0.240
Why?
Chronic Disease
3
2020
544
0.230
Why?
Selection Bias
1
2021
9
0.220
Why?
Fertility
1
2021
19
0.220
Why?
Aminoisobutyric Acids
2
2018
4
0.220
Why?
Leucine
2
2018
18
0.220
Why?
Graft Survival
2
2019
111
0.220
Why?
Aged, 80 and over
8
2020
5234
0.210
Why?
Hepatitis C Antibodies
1
2020
6
0.210
Why?
World Health Organization
1
2020
19
0.210
Why?
Tissue Donors
1
2021
79
0.210
Why?
End Stage Liver Disease
1
2020
17
0.200
Why?
Anilides
2
2019
11
0.200
Why?
2-Naphthylamine
2
2019
4
0.200
Why?
Recurrence
2
2011
389
0.200
Why?
Hemorrhage
1
2020
90
0.200
Why?
Attitude of Health Personnel
1
2021
181
0.190
Why?
Consensus
2
2021
106
0.190
Why?
Drug and Narcotic Control
2
2016
8
0.190
Why?
Hyperemesis Gravidarum
1
2019
1
0.190
Why?
Carcinoma, Hepatocellular
1
2019
41
0.190
Why?
Hepatitis, Autoimmune
1
2019
9
0.190
Why?
Forecasting
1
2019
134
0.190
Why?
United States Food and Drug Administration
2
2016
75
0.180
Why?
Biomedical Research
1
2019
89
0.180
Why?
Transplant Recipients
1
2018
19
0.180
Why?
Internationality
1
2018
26
0.180
Why?
Logistic Models
2
2010
479
0.170
Why?
Follow-Up Studies
4
2015
2028
0.170
Why?
Practice Guidelines as Topic
3
2021
389
0.170
Why?
RNA, Viral
3
2018
163
0.170
Why?
Drug Substitution
1
2017
4
0.160
Why?
Critical Pathways
1
2017
23
0.160
Why?
Dose-Response Relationship, Drug
1
2018
512
0.160
Why?
Infant, Newborn
1
2019
754
0.160
Why?
Patient Participation
1
2017
52
0.160
Why?
Counterfeit Drugs
1
2016
2
0.160
Why?
Commerce
1
2016
12
0.150
Why?
Ascites
1
2016
5
0.150
Why?
Canada
1
2016
57
0.150
Why?
Paracentesis
1
2016
4
0.150
Why?
Fraud
1
2016
15
0.150
Why?
Psychometrics
1
2018
287
0.150
Why?
Quality Control
1
2016
50
0.150
Why?
Safety
1
2016
59
0.150
Why?
Interferons
1
2016
15
0.150
Why?
Eclampsia
1
2016
2
0.150
Why?
HELLP Syndrome
1
2016
2
0.150
Why?
Pre-Eclampsia
1
2016
8
0.150
Why?
Time Factors
3
2016
1902
0.150
Why?
Drug Approval
1
2016
31
0.150
Why?
Hydrogen-Ion Concentration
1
2016
177
0.150
Why?
Directive Counseling
1
2015
15
0.150
Why?
Hospitalization
2
2016
359
0.150
Why?
Benchmarking
1
2015
34
0.150
Why?
Diffusion of Innovation
1
2015
41
0.150
Why?
Isoquinolines
1
2015
16
0.140
Why?
Benzazepines
1
2015
10
0.140
Why?
Administration, Oral
1
2015
164
0.140
Why?
Deficiency Diseases
1
2015
2
0.140
Why?
Severity of Illness Index
1
2020
1240
0.140
Why?
Liver Failure
1
2015
14
0.140
Why?
Indoles
1
2015
58
0.140
Why?
Zinc
1
2015
40
0.140
Why?
Treatment Failure
2
2017
187
0.140
Why?
Kidney Failure, Chronic
1
2017
176
0.140
Why?
Comorbidity
4
2018
562
0.140
Why?
Phenotype
1
2015
379
0.130
Why?
Off-Label Use
1
2014
6
0.130
Why?
Hospitalists
1
2014
7
0.130
Why?
Randomized Controlled Trials as Topic
1
2016
375
0.130
Why?
African Americans
1
2021
818
0.130
Why?
Multivariate Analysis
2
2015
390
0.130
Why?
Cooperative Behavior
1
2014
86
0.120
Why?
Internship and Residency
1
2016
201
0.120
Why?
Health Care Costs
1
2014
81
0.120
Why?
Drug Eruptions
1
2013
14
0.120
Why?
Hematologic Diseases
1
2013
17
0.120
Why?
Viral Nonstructural Proteins
3
2017
9
0.120
Why?
Monitoring, Immunologic
1
2012
2
0.120
Why?
Gastrointestinal Diseases
1
2013
42
0.120
Why?
Quality of Health Care
1
2014
141
0.120
Why?
Drug Combinations
3
2017
88
0.120
Why?
Predictive Value of Tests
2
2017
637
0.110
Why?
Cost of Illness
1
2011
65
0.110
Why?
Drug Carriers
1
2010
8
0.110
Why?
Quality-Adjusted Life Years
2
2021
25
0.100
Why?
CD4-Positive T-Lymphocytes
1
2012
225
0.100
Why?
Polymerase Chain Reaction
1
2010
188
0.100
Why?
Models, Statistical
1
2011
144
0.100
Why?
Odds Ratio
1
2010
327
0.100
Why?
Sensitivity and Specificity
1
2011
580
0.090
Why?
Fluorenes
2
2019
3
0.090
Why?
Hemoglobins
1
2008
81
0.080
Why?
Clinical Trials as Topic
1
2009
378
0.080
Why?
Cross-Sectional Studies
2
2021
986
0.080
Why?
Hospital Costs
2
2016
73
0.070
Why?
Pregnant Women
1
2021
14
0.060
Why?
Non-alcoholic Fatty Liver Disease
1
2019
3
0.050
Why?
Waiting Lists
1
2019
18
0.050
Why?
Tissue and Organ Procurement
1
2019
37
0.050
Why?
Insurance, Major Medical
1
2018
1
0.050
Why?
International Normalized Ratio
1
2018
32
0.040
Why?
Registries
1
2019
214
0.040
Why?
High-Throughput Nucleotide Sequencing
1
2017
42
0.040
Why?
Uridine Monophosphate
1
2017
2
0.040
Why?
Genetic Variation
1
2017
113
0.040
Why?
Decision Support Techniques
1
2017
55
0.040
Why?
Delivery of Health Care, Integrated
1
2017
30
0.040
Why?
Serine Proteases
1
2016
7
0.040
Why?
Internal Medicine
1
2016
34
0.040
Why?
Career Choice
1
2016
33
0.040
Why?
Patient-Centered Care
1
2017
66
0.040
Why?
Pain Management
1
2018
139
0.040
Why?
Cost Savings
1
2016
38
0.040
Why?
Quality Indicators, Health Care
1
2016
43
0.040
Why?
Mental Disorders
1
2018
206
0.040
Why?
Curriculum
1
2016
158
0.040
Why?
Patient Care Team
1
2017
153
0.040
Why?
Early Diagnosis
1
2015
76
0.030
Why?
Reproducibility of Results
1
2018
886
0.030
Why?
Statistics, Nonparametric
1
2015
156
0.030
Why?
Hospital Mortality
1
2016
192
0.030
Why?
Kaplan-Meier Estimate
1
2015
230
0.030
Why?
Linear Models
1
2015
276
0.030
Why?
Databases, Factual
1
2016
391
0.030
Why?
Drug Industry
1
2014
29
0.030
Why?
Clinical Competence
1
2016
274
0.030
Why?
Guideline Adherence
1
2014
77
0.030
Why?
Acquired Immunodeficiency Syndrome
1
2014
100
0.030
Why?
Survival Rate
1
2015
465
0.030
Why?
Immunoassay
1
2012
45
0.030
Why?
Immunity, Cellular
1
2012
68
0.030
Why?
Inpatients
1
2014
154
0.030
Why?
Probability
1
2012
104
0.030
Why?
Disease Progression
1
2015
861
0.030
Why?
Immunosuppressive Agents
1
2012
163
0.030
Why?
Postoperative Complications
1
2012
1083
0.020
Why?
Reau's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description